NCSM

$69.06

Post-MarketAs of Mar 17, 8:00 PM UTC

NCS Multistage Holdings, Inc.

Intraday

Custom Range:
to
No data available for this range. Intraday data may be limited by the exchange.

Recent News

Insider Monkey
Mar 17, 2026

NCS Multistage Holdings (NCSM) Reports Better-than-Expected Results for Q4 2025

NCS Multistage Holdings, Inc. (NASDAQ:NCSM) is included among The $200 Oil Playbook: 10 Energy Stocks Positioned to Outperform as the Strait Remains Closed. NCS Multistage Holdings, Inc. (NASDAQ:NCSM) is a leading provider of highly engineered products and support services that enable oil-and-gas operators to optimize oil and natural gas well completions and field development strategies. […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 12, 2026

Zacks.com featured highlights include BrightSpring Health, Aura Minerals, Constellium and NCS Multistage

BrightSpring Health, Aura Minerals, Constellium and NCS Multistage have been highlighted in this Screen of The Week article.

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
Zacks
Mar 11, 2026

Bet on These 4 High-Flying Stocks With Increasing Cash Flows

BTSG, AUGO, CSTM and NCSM stand out as rising cash flow plays, supported by strong demand trends and sharp earnings estimate upgrades in the past 30 days.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 11, 2026

NCS Multistage (NCSM) is on the Move, Here's Why the Trend Could be Sustainable

If you are looking for stocks that are well positioned to maintain their recent uptrend, NCS Multistage (NCSM) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 10, 2026

Here is Why Growth Investors Should Buy NCS Multistage (NCSM) Now

NCS Multistage (NCSM) is well positioned to outperform the market, as it exhibits above-average growth in financials.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.